Current clinical applications of RNA-LNPs in cancer: a promising horizon for targeted therapies.

EXCLI J · 2025 · PMC11895062 · PMID 40071028

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

But there are still questions that need to be solved and we can see a positive trend in the improvement of the preclinical and clinical stages.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.